000 | 01184 a2200313 4500 | ||
---|---|---|---|
005 | 20250517230237.0 | ||
264 | 0 | _c20190422 | |
008 | 201904s 0 0 eng d | ||
022 | _a1473-5636 | ||
024 | 7 |
_a10.1097/CMR.0000000000000474 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOlaverria Salavaggione, Gonzalo N | |
245 | 0 | 0 |
_aAnalysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma. _h[electronic resource] |
260 |
_bMelanoma research _c10 2018 |
||
300 |
_a390-397 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCyclopentanes _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelanoma _xdrug therapy |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aDuggan, Megan C | |
700 | 1 | _aCarson, William E | |
773 | 0 |
_tMelanoma research _gvol. 28 _gno. 5 _gp. 390-397 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/CMR.0000000000000474 _zAvailable from publisher's website |
999 |
_c28644318 _d28644318 |